Myszor, Iwona T.
Parveen, Zahida
Ottosson, Håkan
Bergman, Peter
Agerberth, Birgitta
Strömberg, Roger
Gudmundsson, Gudmundur H.
Funding for this research was provided by:
University of Iceland research fund
Icelandic Center for Research
Icelandic Center for Research (RANNÍS) University of Iceland research fund
Article History
Received: 31 January 2019
Accepted: 18 April 2019
First Online: 8 May 2019
Competing Interests
: I.T.M., Z.P. and H.O. declare no competing interests. G.H.G., B.A. and R.S. are founders and stockholders in Akthelia Pharmaceuticals that hold a patent on APD compounds, Patent No. US 9,957,226 B2. P.B. is a stockholder in Akthelia Pharmaceuticals.